AMGEN PRESENTS NEW AMG 133 PHASE 1 CLINICAL DATA AT WCIRDC 2022
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new Phase 1 data from AMG 133, a novel bispecific glucose-dependent insulinotropic polypeptide receptor...
Source: prnewswire.com
Highest Dose After News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Highest Dose After. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Highest Dose After Today - Breaking & Trending Today